Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Proceedings of the National Academy of Sciences of the United States of America
|
July 19, 2006
Genes and pathways downstream of telomerase in melanoma metastasis
Sepideh Bagheri, Mehdi Nosrati, Shang Li, et al.
Human Gene Therapy
|
December 21, 2023
Prophylactic Prednisolone Promotes AAV5 Hepatocyte Transduction Through the Novel Mechanism of AAV5 Coreceptor Platelet-Derived Growth Factor Receptor Alpha Upregulation and Innate Immune Suppression
Britta Handyside, Lening Zhang, Bridget Yates, et al.
Molecular Therapy. Methods & Clinical Development
|
August 11, 2020
Induction of ER Stress by an AAV5 BDD FVIII Construct Is Dependent on the Strength of the Hepatic-Specific Promoter
Sylvia Fong, Britta Handyside, Choong-Ryoul Sihn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 9, 2022
Vector genome loss and epigenetic modifications mediate decline in transgene expression of AAV5 vectors produced in mammalian and insect cells
Britta Handyside, Ashrafali Mohamed Ismail, Lening Zhang, et al.
Hepatology (Baltimore, Md.)
|
May 1, 2026
BMN 349, a small molecule inhibitor of Z alpha-1 antitrypsin polymerization, increases secretion and reduces intrahepatic inclusions in a mouse model of disease
Britta Handyside, Heather Wenzel, Donald Mackenzie, et al.
Molecular Therapy. Methods & Clinical Development
|
September 12, 2022
Young mice administered adult doses of AAV5-hFVIII-SQ achieve therapeutic factor VIII expression into adulthood
Lening Zhang, Bridget Yates, Ryan Murphy, et al.
Plos One
|
January 3, 2025
Intracerebroventricular administration of a modified hexosaminidase ameliorates late-stage neurodegeneration in a GM2 mouse model
Manuel E Lopez, Daniel Wendt, Roger Lawrence, et al.
The Journal of Biological Chemistry
|
September 5, 2019
Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice
Joseph C Chen, Amanda R Luu, Nathan Wise, et al.
The Journal of Biological Chemistry
|
October 28, 2022
Intracerebroventricular dosing of N-sulfoglucosamine sulfohydrolase in mucopolysaccharidosis IIIA mice reduces markers of brain lysosomal dysfunction
Jenna Magat, Samantha Jones, Brian Baridon, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Proceedings of the National Academy of Sciences of the United States of America
|
July 19, 2006
Genes and pathways downstream of telomerase in melanoma metastasis
Sepideh Bagheri, Mehdi Nosrati, Shang Li, et al.
Human Gene Therapy
|
December 21, 2023
Prophylactic Prednisolone Promotes AAV5 Hepatocyte Transduction Through the Novel Mechanism of AAV5 Coreceptor Platelet-Derived Growth Factor Receptor Alpha Upregulation and Innate Immune Suppression
Britta Handyside, Lening Zhang, Bridget Yates, et al.
Molecular Therapy. Methods & Clinical Development
|
August 11, 2020
Induction of ER Stress by an AAV5 BDD FVIII Construct Is Dependent on the Strength of the Hepatic-Specific Promoter
Sylvia Fong, Britta Handyside, Choong-Ryoul Sihn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 9, 2022
Vector genome loss and epigenetic modifications mediate decline in transgene expression of AAV5 vectors produced in mammalian and insect cells
Britta Handyside, Ashrafali Mohamed Ismail, Lening Zhang, et al.
Hepatology (Baltimore, Md.)
|
May 1, 2026
BMN 349, a small molecule inhibitor of Z alpha-1 antitrypsin polymerization, increases secretion and reduces intrahepatic inclusions in a mouse model of disease
Britta Handyside, Heather Wenzel, Donald Mackenzie, et al.
Molecular Therapy. Methods & Clinical Development
|
September 12, 2022
Young mice administered adult doses of AAV5-hFVIII-SQ achieve therapeutic factor VIII expression into adulthood
Lening Zhang, Bridget Yates, Ryan Murphy, et al.
Plos One
|
January 3, 2025
Intracerebroventricular administration of a modified hexosaminidase ameliorates late-stage neurodegeneration in a GM2 mouse model
Manuel E Lopez, Daniel Wendt, Roger Lawrence, et al.
The Journal of Biological Chemistry
|
September 5, 2019
Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice
Joseph C Chen, Amanda R Luu, Nathan Wise, et al.
The Journal of Biological Chemistry
|
October 28, 2022
Intracerebroventricular dosing of N-sulfoglucosamine sulfohydrolase in mucopolysaccharidosis IIIA mice reduces markers of brain lysosomal dysfunction
Jenna Magat, Samantha Jones, Brian Baridon, et al.
Page
of 4